Unmasking the expression of PD-L1 in Myeloid Derived Suppressor Cells: A case study in lung cancer to discover new drugs with specific on-target efficacy

Unmasking the expression of PD-L1 in Myeloid Derived Suppressor Cells: A case study in lung cancer to discover new drugs with specific on-target efficacy

Bibliographic Details
Main Authors:	Laura G. Rico, Andrés Aguilar Hernández, Michael D. Ward, Jolene A. Bradford, Jordi Juncà, Rafael Rosell, Jordi Petriz
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Translational Oncology
Subjects:	Flow cytometry PD-L1 Immunotherapy MDSCs
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523320304617

Similar Items

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
by: Mithunah Krishnamoorthy, et al.
Published: (2021-05-01)

The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients
by: Jiuxing Feng, et al.
Published: (2020-12-01)

Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis
by: Wei-Shuyi Ruan, et al.
Published: (2020-07-01)

Targeting myeloid-derived suppressor cells for cancer therapy
by: Hongchao Tang, et al.
Published: (2021-11-01)

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives
by: Filippos Koinis, et al.
Published: (2021-12-01)

Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis
by: Panpan Liu, et al.
Published: (2021-03-01)

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion
by: Zeda Zhao, et al.
Published: (2024-02-01)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
by: Woong-Jai Won, et al.
Published: (2019-01-01)

Function of reactive oxygen species in myeloid-derived suppressor cells
by: Jiaojiao Huang, et al.
Published: (2023-08-01)

Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke
by: Haomin Yan, et al.
Published: (2023-03-01)

Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
by: Hui Xuan Lim, et al.
Published: (2020-05-01)

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
by: Dehong Yan, et al.
Published: (2019-06-01)

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
by: Itay Raphael, et al.
Published: (2021-05-01)

Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)

Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
by: Min Li, et al.
Published: (2018-12-01)

Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses
by: Eleni Kontaki, et al.
Published: (2017-04-01)

Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination
by: Annkristin Heine, et al.
Published: (2017-08-01)

Myeloid-derived suppressor cells—new and exciting players in lung cancer
by: Zhenzhen Yang, et al.
Published: (2020-01-01)

Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
by: Karolina Okła
Published: (2023-07-01)

Flow-cytometry-based protocols for human blood/marrow immunophenotyping with minimal sample perturbation
by: Laura G. Rico, et al.
Published: (2021-12-01)

Role of myeloid-derived suppressor cells in chronic brucellosis
by: Shuiping Hou, et al.
Published: (2024-01-01)

Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
by: Yufei Wang, et al.
Published: (2020-04-01)

Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice
by: James D. Barnett, et al.
Published: (2022-07-01)

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
by: Katarzyna Tomela, et al.
Published: (2023-03-01)

Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
by: Haoran Zha, et al.
Published: (2017-10-01)

Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion
by: Gan Zhang, et al.
Published: (2022-12-01)

Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice
by: Yoshikazu Fujikawa, et al.
Published: (2024-03-01)

Myeloid-derived suppressor cells and vaccination against pathogens
by: Estefanía Prochetto, et al.
Published: (2022-09-01)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
by: Catia Giovannini, et al.
Published: (2023-03-01)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
by: Christos Demosthenous, et al.
Published: (2021-05-01)

Paradoxes in the Phenotype, Frequency and Roles of Myeloid-Derived Suppressor Cells During HIV Infection
by: Ademe M
Published: (2020-04-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance
by: Àngel Bistué-Rovira, et al.
Published: (2024-02-01)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
by: Francesca Maria Consonni, et al.
Published: (2019-05-01)

Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
by: Junya Okabe, et al.
Published: (2023-10-01)

Involvement of impaired CD8+ mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome
by: Mengting Zhu, et al.
Published: (2021-11-01)

Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling
by: Jiale an, et al.
Published: (2021-01-01)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
by: Celia Camacho-Toledano, et al.
Published: (2022-11-01)

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
by: Augusto Bleve, et al.
Published: (2022-01-01)

E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells
by: Manman Liang, et al.
Published: (2023-10-01)